Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends
As we approach the final weeks of 2025, the U.S. healthcare sector has transitioned from a defensive stalwart…
1 Major Factor Behind the Healthcare Sector’s Recent Surge
Eli Lilly’s GLP-1 drug became the world’s best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other…
Information Technology Leads Selloff; Healthcare Bucks Downward Trend
MT Newswires -Shutterstock The healthcare sector was the only one in the green, gaining just 0.2% at midday…
Three Healthcare Buys That Wall Street Loves
Healthcare stocks are hot right now. Several factors are driving them higher, including innovations in areas like heart…
Michael Burry Is Betting on This 1 Under-the-Radar Healthcare Stock. Should You?
Michael Burry is a Wall Street investor who gained fame after accurately predicting the 2008 housing crisis. In…
UPS expands healthcare reach with completion of Andlauer Healthcare deal
UPS has completed the acquisition of Andlauer Healthcare Group, a provider of logistics and refrigerated transportation services for…
2 Outstanding Healthcare Stocks to Buy and Hold for a Decade
One great thing about the healthcare sector is that the need for medical services never goes out of…
Healthcare’s employment growth clouded by immigration crackdown, Medicaid cuts
The healthcare sector has accounted for nearly half of this year’s U.S. job growth. But economists say immigration…
China’s healthcare sector sees record US$10.6 billion fundraising as biotech booms
China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand…
Is This the Right Time to Consider Healthcare ETFs?
U.S. healthcare stocks are currently trading at the biggest discount relative to the broader market in 30 years,…
MMA urges halt to Poisons (Amendment) Bill, wants govt to engage healthcare stakeholders
PETALING JAYA: The Malaysian Medical Association (MMA) has voiced strong concern to the Poisons (Amendment) Bill 2025, urging…
Legal review advised for drug pricing order to ensure compliance, says doctor
JOHOR BARU: The newly gazetted Price Control and Anti-Profiteering (Price Marking for Drugs) Order 2025 should be referred…